Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
1100
-
Total 13F shares, excl. options
-
71.7M
-
Shares change
-
-1.2M
-
Total reported value, excl. options
-
$29.7B
-
Value change
-
-$542M
-
Put/Call ratio
-
2.1
-
Number of buys
-
420
-
Number of sells
-
-572
-
Price
-
$413.44
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q4 2024
1,277 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q4 2024.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 1,100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.7M shares
of 80.8M outstanding shares and own 88.69% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.71M shares), BlackRock, Inc. (8.47M shares), STATE STREET CORP (3.64M shares), Fundsmith LLP (2.66M shares), GEODE CAPITAL MANAGEMENT, LLC (2.3M shares), BAMCO INC /NY/ (2.01M shares), MORGAN STANLEY (1.63M shares), ALLIANCEBERNSTEIN L.P. (1.24M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.16M shares), and Invesco Ltd. (1.16M shares).
This table shows the top 1100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.